Document:

Exhibit

Exhibit 10.11
 
March 6, 2018

Jennifer Pileggi 
C/O Zuora, Inc.
3050 South Delaware Street Suite 301
San Mateo, CA 94403

Re:    Continued Employment with Zuora, Inc.

Dear Jennifer,

This employment letter confirms your continued employment as SVP General Counsel with Zuora, Inc., a Delaware Corporation (the “Company” or “Zuora”). You will continue to report to Tien Tzuo, Zuora’s Chief Executive Officer.

1.Salary and Variable Compensation. Your annual base salary will be Two Hundred Seventy Five Thousand Dollars ($275,000) per year and will be subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time. The Company currently pays salary on the 15th and last day of each month. You will also be eligible to participate in the executive incentive compensation plan which will provide you with the opportunity to earn variable compensation.

2.Benefits. In addition, you will be eligible to participate in regular health insurance, bonus and other employee benefit plans established by the Company for its employees from time to time. As an executive, you will also be entitled to participate in our “unlimited vacation” policy which allows you to take time off as needed. Except as provided below, the Company reserves the right to change or otherwise modify, in its sole discretion, the preceding terms of employment, as well as any of the terms set forth herein at any time in the future.

3.Confidentiality. As an employee of the Company, you will have access to certain confidential information of the Company and you may, during the course of your employment, develop certain information or inventions that will be the property of the Company. You acknowledge that you have signed and are bound by the terms of the Company’s standard “Employee Invention Assignment and Confidentiality Agreement.” During the period that you render services to the Company, you agree to not engage in any employment, business or activity that is in any way competitive with the business or proposed business of the Company. You will disclose to the Company in writing any other gainful employment, business or activity that you are currently associated with or participate in that competes with the Company. You will not assist any other person or organization in competing with the Company or in preparing to engage in competition with the business or proposed business of the Company.

Employment Letter 
Page 2

4.Equity. You currently hold Company equity grants. You will be eligible for future discretionary equity grants at the sole discretion of the Company. We also acknowledge that you have entered into a Change in Control and Severance Agreement with the Company.

5.Non-Solicitation. During your employment with the Company and for a period of one (1) year thereafter, you will not directly or indirectly solicit away employees or consultants of the Company for your own benefit or for the benefit of any other person or entity.

6.At Will Employment. While we look forward to a continued long and profitable relationship, you are an at-will employee of the Company, which means the employment relationship can be terminated by either of us for any reason, at any time, with or without prior notice and with our without cause. Any statements or representations to the contrary (and, indeed, any statements contradicting any provision in this letter) should be regarded by you as ineffective. Further, your participation in any stock option or benefit program is not to be regarded as assuring you of continuing employment for any particular period of time. Any modification or change in your at will employment status may only occur by way of a written employment agreement signed by you and the Chief Executive Officer of the Company.

7.Arbitration. You and the Company shall submit to mandatory and exclusive binding arbitration of any controversy or claim arising out of, or relating to, this Agreement or any breach hereof, provided, however, that the parties retain their right to, and shall not be prohibited, limited or in any other way restricted from, seeking or obtaining equitable relief from a court having jurisdiction over the parties. Such arbitration shall be governed by the Federal Arbitration Act and conducted through the American Arbitration Association in the State of California, Santa Clara County, before a single neutral arbitrator, in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association in effect at that time. The parties hereby waive any rights they may have to have any such claims tried before a judge or jury. The parties may conduct only essential discovery prior to the hearing, as defined by the AAA arbitrator. The arbitrator shall issue a written decision that contains the essential findings and conclusions on which the decision is based. You shall bear only those costs of arbitration you would otherwise bear had you brought a claim covered by this Agreement in court. Judgment upon the determination or award rendered by the arbitrator may be entered in any court having jurisdiction thereof.

	
		
	Very truly yours,
	 

	/s/ Tien Tzuo
	 

	Tien Tzuo
	 

	Chief Executive Officer

	 
	 

I have read and understood this employment letter and hereby acknowledge, accept and agree to the terms as set forth above and further acknowledge that no other commitments were made to me as part of my employment except as specifically set forth herein.

     	
				
	/s/ Jennifer Pileggi
	 
	Date signed:
	March 7, 2018

	Jennifer PileggiExhibit 10.1

 

FIRST AMENDMENT TO AGREEMENT AND PLAN
OF MERGER

 

THIS
FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (the “Amendment”) is made and entered into as of April 12, 2019
(the “Effective Date”), by and between HealthLynked Corp., a Nevada corporation (the “Parent”),
HLYK Florida, LLC, a Florida limited liability company (the “Company”), Hughes Center for Functional Medicine,
P.A. (the “Target”), and Pamela A. Hughes, D.O. (the “Seller”).

 

WHEREAS,
Parent, Company, Target, and Seller are parties to an Agreement and Plan of Merger, dated January 15, 2019 (the “Agreement”)
pursuant to which the parties intend to effect a merger of Target with and into Company, upon which time Target will cease to
exist and Company will continue as the survive entity and wholly owned subsidiary of Parent; and

 

WHEREAS, the parties have agreed to amend the
terms of the Agreement as set forth herein.

 

NOW, THEREFORE, in consideration
of the promises and mutual agreements contained herein, the parties do hereby agree as follows:

 

		1.	Sections 5.1 and 5.2 of the Agreement shall be and are
hereby deleted in its entirety and replaced with the following:

 

		5.1.	$500,000 payable at the Closing, as defined below;

 

		5.2.	3,968,254 common shares of Parent with an aggregate value
of $1,000,000 (valued at $0.252 per common share) shall be issued to the Seller at the Closing;

 

		2.	Except as otherwise expressly provided herein, all other
terms and conditions of the Agreement shall remain unchanged and shall continue to be in full force and effect, and the terms
of this Amendment shall be deemed a part of the Agreement as if fully set forth therein. To the extent any provision of this Amendment
is inconsistent or shall conflict with any provision in the Agreement, the terms of this Amendment shall prevail.

 

		3.	This
                                         Amendment may be executed in one or more counterparts, each of which shall be deemed
                                         an original, but all of which when taken together shall constitute one and the same instrument.
                                         Transmission of images of signed signature pages by facsimile, e-mail, or other electronic
                                         means shall have the same effect as the delivery of manually signed documents in person.

 

SIGNATURE PAGE FOLLOWS

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Amendment as of the Effective Date.

 

	COMPANY:	 	SELLER:
	 	 	 	 
	HLYK FLORIDA, LLC	 	PAMELA A. HUGHES,
    D.O.
	 	 	 	 
	By:	/s/ George O’Leary	 	/s/ Pamela A. Hughes
    D.O.
	Name:	George O’Leary	 	Pamela A. Hughes,
    D.O., individually
	Title:	CFO	 	 

 

	PARENT:	 	TARGET:
	 	 	 	 	 
	HEALTHLYNKED CORP.	 	HUGHES CENTER FOR FUNCTIONAL MEDICINE, P.A.
	 	 	 	 	 
	By:	/s/ George O’Leary	 	By:	/s/ Pamela A. Hughes
    D.O.
	Name:	George O’Leary	 	Name:	Pamela A. Hughes
    D.O.
	Title:	CFO	 	Title:	Physician/Owner

 

 

 2[EXECUTION
VERSION]

 

PURCHASE
AGREEMENT

 

PURCHASE
AGREEMENT (the “Agreement”), dated as of April 12, 2019, by and between MGT CAPITAL INVESTMENTS, INC.,
a Delaware corporation (the “Company”), and Iliad Research and Trading, L.P., a Utah limited partnership (the
“Investor”).

 

WHEREAS:

 

Subject
to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wishes to
buy from the Company, 17,500,000 shares (the “Purchase Shares”) of the Company’s common stock, $0.001
par value per share (the “Common Stock”), at a price of $0.03 per Purchase Share, for a total purchase price
of Five Hundred Twenty Five Thousand Dollars ($525,000).

 

NOW
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 

1.
CERTAIN DEFINITIONS.

 

For
purposes of this Agreement, the following terms shall have the following meanings:

 

(a)
“Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

 

(b)
“Base Prospectus” means the Company’s final base prospectus, a preliminary form of which is included
in the Registration Statement, including the documents incorporated by reference therein.

 

(c)
“Business Day” means any day on which the Principal Market is open for trading, including any day on which
the Principal Market is open for trading for a period of time less than the customary time.

 

(d)
“Confidential Information” means any information disclosed by either party to the other party, either directly
or indirectly, in writing, orally or by inspection of tangible objects (including, without limitation, documents, prototypes,
samples, plant and equipment), which is designated as “Confidential,” “Proprietary” or some similar designation.
Information communicated orally shall be considered Confidential Information if such information is confirmed in writing as being
Confidential Information within ten (10) Business Days after the initial disclosure. Confidential Information may also include
information disclosed to a disclosing party by third parties. Confidential Information shall not, however, include any information
which (i) was publicly known and made generally available in the public domain prior to the time of disclosure by the disclosing
party; (ii) becomes publicly known and made generally available after disclosure by the disclosing party to the receiving party
through no action or inaction of the receiving party; (iii) is already in the possession of the receiving party without confidential
restriction at the time of disclosure by the disclosing party as shown by the receiving party’s files and records immediately
prior to the time of disclosure; (iv) is obtained by the receiving party from a third party without a breach of such third party’s
obligations of confidentiality; (v) is independently developed by the receiving party without use of or reference to the disclosing
party’s Confidential Information, as shown by documents and other competent evidence in the receiving party’s possession;
or (vi) is required by law to be disclosed by the receiving party, provided that the receiving party gives the disclosing party
prompt written notice of such requirement prior to such disclosure and assistance in obtaining an order protecting the information
from public disclosure.

 

    	 	 	 

     

    

 

(e)
“Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

 

(f)
“DTC” means The Depository Trust Company, or any successor performing substantially the same function for the
Company.

 

(g)
“DWAC Shares” means shares of Common Stock that are (i) issued in electronic form, (ii) freely tradable and
transferable and without restriction on resale and (iii) timely credited by the Company to the Investor or its designee’s
specified Deposit/Withdrawal at Custodian (DWAC) account with DTC under its Fast Automated Securities Transfer (FAST) Program
or any similar program hereafter adopted by DTC performing substantially the same function.

 

(h)
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.

 

(i)
“Initial Prospectus Supplement” means the prospectus supplement of the Company relating to the Purchase Shares,
including the accompanying Base Prospectus, to be prepared and filed by the Company with the SEC pursuant to Rule 424(b)(5) under
the Securities Act and in accordance with Section 5(a) hereof, together with all documents and information incorporated therein
by reference.

 

(j)
“Material Adverse Effect” means any material adverse effect on (i) the enforceability of any Transaction Document,
(ii) the results of operations, assets, business or financial condition of the Company and its Subsidiaries, taken as a whole,
other than any material adverse effect that resulted primarily from (A) any change in the United States or foreign economies or
securities or financial markets in general that does not have a disproportionate effect on the Company and its Subsidiaries, taken
as a whole, (B) any change that generally affects the industry in which the Company and its Subsidiaries operate that does not
have a disproportionate effect on the Company and its Subsidiaries, taken as a whole, (C) any change arising in connection with
earthquakes, hostilities, acts of war, sabotage or terrorism or military actions or any escalation or material worsening of any
such hostilities, acts of war, sabotage or terrorism or military actions existing as of the date hereof, (D) any action taken
by the Investor, its affiliates or its successors and assigns with respect to the transactions contemplated by this Agreement,
(E) the effect of any change in applicable laws or accounting rules that does not have a disproportionate effect on the Company
and its Subsidiaries, taken as a whole, or (F) any change resulting from compliance with terms of this Agreement or the consummation
of the transactions contemplated by this Agreement, or (iii) the Company’s ability to perform in any material respect on
a timely basis its obligations under any Transaction Document to be performed as of the date of determination.

 

(k)
“Person” means an individual or entity including but not limited to any limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization and a government or any department or agency thereof.

 

(l)
“Principal Market” means the OTCQB operated by the OTC Markets Group, Inc. (or any nationally recognized successor
thereto); provided, however, that in the event the Company’s Common Stock is ever listed or traded on The NASDAQ Capital
Market, The NASDAQ Global Market, The NASDAQ Global Select Market, the New York Stock Exchange, the NYSE American, the NYSE Arca,
the OTC Bulletin Board, or the OTCQX operated by the OTC Markets Group, Inc. (or any nationally recognized successor to any of
the foregoing), then the “Principal Market” shall mean such other market or exchange on which the Company’s
Common Stock is then listed or traded.

 

    	 	-2-	 

     

    

 

(m)
“Prospectus” means the Base Prospectus, as supplemented by any Prospectus Supplement (including the Initial
Prospectus Supplement), including the documents and information incorporated by reference therein.

 

(n)
“Prospectus Supplement” means any prospectus supplement to the Base Prospectus (including the Initial Prospectus
Supplement) filed with the SEC pursuant to Rule 424(b) under the Securities Act in connection with the transactions contemplated
by this Agreement, including the documents and information incorporated by reference therein.

 

(o)
“Registration Statement” means the effective registration statement on Form S-3 (Commission File No. 333-225589)
filed by the Company with the SEC pursuant to the Securities Act for the registration of shares of its Common Stock, including
the Purchase Shares, and certain other securities, as such Registration Statement has been or may be amended and supplemented
from time to time, including all documents filed as part thereof or incorporated by reference therein, and including all information
deemed to be a part thereof at the time of effectiveness pursuant to Rule 430B of the Securities Act, including any comparable
successor registration statement filed by the Company with the SEC pursuant to the Securities Act for the registration of shares
of its Common Stock, including the Purchase Shares.

 

(p)
“SEC” means the U.S. Securities and Exchange Commission.

 

(q)
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

(r)
“Subsidiary” means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly,
owns a majority of the voting stock or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21)
of Regulation S-K promulgated under the Securities Act.

 

(s)
“Transaction Documents” means, collectively, this Agreement and the schedules and exhibits hereto, and each
of the other agreements, documents, certificates and instruments entered into or furnished by the parties hereto in connection
with the transactions contemplated hereby and thereby.

 

(t)
“Transfer Agent” means VStock Transfer LLC, or such other Person who is then serving as the transfer agent
for the Company in respect of the Common Stock.

 

2.
PURCHASE OF COMMON STOCK.

 

Subject
to the terms and conditions set forth in this Agreement, the Company desires to sell to the Investor, and the Investor desires
to purchase from the Company, the Purchase Shares as follows:

 

(a)
Purchase of Common Stock. Upon the satisfaction of the conditions set forth in Sections 7 and 8 hereof (the “Closing”
and the date of satisfaction of such conditions the “Closing Date”), the Investor shall purchase from the Company,
and the Company shall issue or cause to be issued and sell to the Investor, for a total purchase price of Five Hundred Twenty
Five Thousand Dollars ($525,000) (the “Purchase Price”), 17,500,000 Purchase Shares, at a price of $0.03 per
Purchase Share.

 

    	 	-3-	 

     

    

 

(b)
Payment of Purchase Price. The Investor shall pay the Purchase Price to the Company as full payment for all of the Purchase
Shares to be purchased by it hereunder by wire transfer of immediately available funds. Upon execution of this Agreement, the
Investor will wire the Purchase Price to the law firm of Hansen Black Anderson Ashcraft PLLC (“HBAA”) to be
held in escrow. On the same Business Day that the Investor receives all of the Purchase Shares as DWAC Shares, the Investor will
direct HBAA to wire the Purchase Price to the Company on or before the following Business Day. All payments made under this Agreement
shall be made in lawful money of the United States of America or wire transfer of immediately available funds to the account designated
by the Company by written notice to the Investor prior to the date of this Agreement.

 

3.
INVESTOR’S REPRESENTATIONS AND WARRANTIES.

 

The
Investor represents and warrants to the Company that as of the date hereof and as of the Closing Date:

 

(a)
Organization, Authority. Investor is an entity duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization, with the requisite power and authority to enter into and to consummate the transactions
contemplated by this Agreement and otherwise to carry out its obligations hereunder and thereunder.

 

(c)
Accredited Investor Status. The Investor is an “accredited investor” as that term is defined in Rule 501(a)(3)
of Regulation D promulgated under the Securities Act.

 

(d)
Information. The Investor understands that its investment in the Purchase Shares involves a high degree of risk. The Investor
(i) is able to bear the economic risk of an investment in the Purchase Shares including a total loss thereof, (ii) has such knowledge
and experience in financial and business matters that it is capable of evaluating the merits and risks of the proposed investment
in the Purchase Shares and (iii) has had an opportunity to ask questions of and receive answers from the officers of the Company
concerning the financial condition and business of the Company and others matters related to an investment in the Purchase Shares.
Neither such inquiries nor any other due diligence investigations conducted by the Investor or its representatives shall modify,
amend or affect the Investor’s right to rely on the Company’s representations and warranties contained in Section
4 below. The Investor has sought such accounting, legal and tax advice from its own independent advisors as it has considered
necessary to make an informed investment decision with respect to its acquisition of the Purchase Shares.

 

(e)
No Governmental Review. The Investor understands that no U.S. federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Purchase Shares or the fairness or suitability of an investment
in the Purchase Shares nor have such authorities passed upon or endorsed the merits of the offering of the Purchase Shares.

 

(f)
Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Investor
and is a valid and binding agreement of the Investor enforceable against the Investor in accordance with its terms, subject as
to enforceability to general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

(g)
No Short Selling. The Investor represents and warrants to the Company that at no time prior to the date of this Agreement
has the Investor or any of its agents, representatives or affiliates engaged in or effected, in any manner whatsoever, directly
or indirectly, any (i) “short sale” (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of
the Common Stock or (ii) hedging transaction, which establishes a net short position with respect to the Common Stock.

 

    	 	-4-	 

     

    

 

4.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The
Company represents and warrants to the Investor that, except as set forth in the disclosure schedules attached hereto, which exceptions
shall be deemed to be a part of the representations and warranties made hereunder, as of the date hereof and as of the Closing
Date:

 

(a)
Organization and Qualification. The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite
corporate power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither
the Company nor any of its Subsidiaries is in violation or default of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents. Each of the Company and its Subsidiaries is duly qualified
to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature
of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect and no
proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification. The Company has no Subsidiaries except as set forth on Exhibit 21.1 to the Company’s
Annual Report on Form 10-K filed with the Commission on April 2, 2018.

 

(b)
Authorization; Enforcement; Validity. (i) The Company has the requisite corporate power and authority to enter into and
perform its obligations under this Agreement and each of the other Transaction Documents, and to issue the Purchase Shares in
accordance with the terms hereof and thereof, (ii) the execution and delivery of this Agreement and each of the other Transaction
Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby, including without limitation,
the issuance of the Purchase Shares pursuant to this Agreement, have been duly authorized by the Company’s Board of Directors
and no further consent or authorization is required by the Company, its Board of Directors or its stockholders, (iii) this Agreement
has been and each of the other Transaction Document shall be on the Closing Date, duly executed and delivered by the Company and
(iv) this Agreement constitutes, and each other Transaction Document upon its execution on behalf of the Company on the Closing
Date, shall on the Closing Date constitute, the valid and binding obligations of the Company enforceable against the Company in
accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’
rights and remedies. The Board of Directors of the Company has approved the resolutions (the “Signing Resolutions”)
to authorize this Agreement, the other Transaction Documents and the transactions contemplated hereby and thereby. The Signing
Resolutions are valid, in full force and effect and have not been modified or supplemented in any respect. The Company has delivered
to the Investor a true and correct copy of minutes of a meeting of the Board of Directors of the Company at which the Signing
Resolutions were duly adopted by the Board of Directors or a unanimous written consent adopting the Signing Resolutions executed
by all of the members of the Board of Directors of the Company. Except as set forth in this Agreement, no other approvals or consents
of the Company’s Board of Directors, any authorized committee thereof, and/or stockholders is necessary under applicable
laws and the Company’s Articles of Incorporation and/or Bylaws to authorize the execution and delivery of this Agreement
or any of the transactions contemplated hereby, including, but not limited to, the issuance of the Purchase Shares.

 

    	 	-5-	 

     

    

 

(c)
Capitalization. As of the date hereof, the authorized capital stock of the Company is set forth in the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30, 2018. Except as disclosed in the SEC Documents (as defined below)
or Schedule 4(c), (i) no shares of the Company’s capital stock are subject to preemptive rights or any other similar rights
or any liens or encumbrances suffered or permitted by the Company, (ii) there are no outstanding debt securities, (iii) there
are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries, or contracts,
commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional
shares of capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of
the Company or any of its Subsidiaries, (iv) there are no agreements or arrangements under which the Company or any of its Subsidiaries
is obligated to register the sale of any of their securities under the Securities Act, (v) there are no outstanding securities
or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound
to redeem a security of the Company or any of its Subsidiaries, (vi) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Purchase Shares as described in this Agreement and (vii) the
Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or
agreement. Unless disclosed in the SEC Documents, the Company has furnished to the Investor true and correct copies of the Company’s
articles of incorporation, as amended and as in effect on the date hereof (the “Articles of Incorporation”),
and the Company’s Bylaws, as amended and as in effect on the date hereof (the “Bylaws”), and summaries
of the material terms of all securities convertible into or exercisable for Common Stock, if any, and copies of any documents
containing the material rights of the holders thereof in respect thereto that are not disclosed in the SEC Documents.

 

(d)
Issuance of Purchase Shares. Upon issuance and payment therefor in accordance with the terms and conditions of this Agreement,
the Purchase Shares shall be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens, charges,
restrictions, rights of first refusal and preemptive rights with respect to the issue thereof, and will be issued in compliance
with all federal and state securities laws, with the holders being entitled to all rights accorded to a holder of shares of Common
Stock. The Purchase Shares are being issued pursuant to the Registration Statement and the issuance of the Purchase Shares has
been registered by the Company pursuant to the Securities Act. Upon receipt of the Purchase Shares, the Investor will have good
and marketable title to such Purchase Shares and such Purchase Shares will be immediately freely tradable.

 

    	 	-6-	 

     

    

 

(e)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Purchase
Shares) will not (i) result in a violation of the Articles of Incorporation, any Certificate of Designations, Preferences and
Rights of any outstanding series of preferred stock of the Company or the Bylaws or (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries
is a party, or result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws and regulations and the rules and regulations of the Principal Market applicable to the Company or any of its Subsidiaries)
or by which any property or asset of the Company or any of its Subsidiaries is bound or affected, except in the case of conflicts,
defaults, terminations, amendments, accelerations, cancellations and violations under clause (ii), which could not reasonably
be expected to result in a Material Adverse Effect. Neither the Company nor its Subsidiaries is in violation of any term of or
in default under its Articles of Incorporation, any Certificate of Designation, Preferences and Rights of any outstanding series
of preferred stock of the Company or Bylaws or their organizational charter or bylaws, respectively. Neither the Company nor any
of its Subsidiaries is in violation of any term of or is in default under any material contract, agreement, mortgage, indebtedness,
indenture, instrument, judgment, decree or order or any statute, rule or regulation applicable to the Company or its Subsidiaries,
except for possible conflicts, defaults, terminations or amendments that could not reasonably be expected to have a Material Adverse
Effect. The business of the Company and its Subsidiaries is not being conducted, and shall not be conducted, in violation of any
law, ordinance or regulation of any governmental entity, except for possible violations, the sanctions for which either individually
or in the aggregate could not reasonably be expected to have a Material Adverse Effect. Except as required under the Securities
Act or applicable state securities laws and the rules and regulations of the Principal Market, the Company is not required to
obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency or any
regulatory or self-regulatory agency in order for it to execute, deliver or perform any of its obligations under or contemplated
by the Transaction Documents in accordance with the terms hereof or thereof. Except as set forth elsewhere in this Agreement,
all consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding
sentence shall be obtained or effected on or prior to the Closing Date. Except as disclosed in the SEC Documents, since one year
prior to the date hereof, the Company has not received nor delivered any notices or correspondence from or to the Principal Market,
other than notices with respect to listing of additional shares of Common Stock and other routine correspondence. Except as disclosed
in the SEC Documents, the Principal Market has not commenced any delisting proceedings against the Company.

 

(f)
SEC Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the twelve months preceding the date hereof (or such shorter period as the Company was required by law or regulation
to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC Documents”) on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Documents prior to the expiration of any such extension. As of their respective
dates and to the Company’s knowledge, the SEC Documents complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable. None of the SEC Documents, when filed, contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
SEC Documents comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United
States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case
of unaudited statements, to normal, immaterial, year-end audit adjustments. Except as set forth in the SEC Documents, or otherwise
filed with the Commission and available on Edgar, the Company has received no written notices or written correspondence from the
SEC for the one year preceding the date hereof. To the Company’s knowledge, the SEC has not commenced any enforcement
proceedings against the Company.

 

    	 	-7-	 

     

    

 

(g)
Absence of Certain Changes. Except as disclosed in the SEC Documents, since December 31, 2018, there has been no material
adverse change in the business, properties, operations, financial condition or results of operations of the Company or its Subsidiaries.
The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any Bankruptcy
Law nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors intend to initiate
involuntary bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able to pay its debts as
they become due.

 

(h)
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its Subsidiaries,
threatened against or affecting the Company, the Common Stock or any of the Company’s or its Subsidiaries’ officers
or directors in their capacities as such, which could reasonably be expected to have a Material Adverse Effect.

 

(i)
Acknowledgment Regarding Investor’s Status. The Company acknowledges and agrees that the Investor is acting solely
in the capacity of arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby
and thereby. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby and
any advice given by the Investor or any of its representatives or agents in connection with the Transaction Documents and the
transactions contemplated hereby and thereby is merely incidental to the Investor’s purchase of the Purchase Shares. The
Company further represents to the Investor that the Company’s decision to enter into the Transaction Documents has been
based solely on the independent evaluation by the Company and its representatives and advisors.

 

(j)
No Integrated Offering. Neither the Company, nor or any of its affiliates, nor any Person acting on their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause this offering of the Purchase Shares to be integrated with prior offerings by the Company in a manner that would require
stockholder approval pursuant to the rules of the Principal Market on which any of the securities of the Company are listed or
designated. The issuance and sale of the Purchase Shares hereunder does not contravene the rules and regulations of the Principal
Market.

 

(k)
Intellectual Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all material
trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions,
licenses, approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as
now conducted. None of the Company’s material trademarks, trade names, service marks, service mark registrations, service
names, patents, patent rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other
intellectual property rights have expired or terminated, or, by the terms and conditions thereof, could expire or terminate within
two years from the date of this Agreement. The Company and its Subsidiaries do not have any knowledge of any infringement by the
Company or its Subsidiaries of any material trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses,
service names, service marks, service mark registrations, trade secret or other similar rights of others, or of any such development
of similar or identical trade secrets or technical information by others, and there is no claim, action or proceeding being made
or brought against, or to the Company’s knowledge, being threatened against, the Company or its Subsidiaries regarding trademark,
trade name, patents, patent rights, invention, copyright, license, service names, service marks, service mark registrations, trade
secret or other infringement, which could reasonably be expected to have a Material Adverse Effect.

 

    	 	-8-	 

     

    

 

(l)
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with any and all applicable foreign, federal,
state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received all permits, licenses
or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in
compliance with all terms and conditions of any such permit, license or approval, except where, in each of the three foregoing
clauses, the failure to so comply could not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect.

 

(m)
Title. Except as set forth in the SEC Documents, the Company and its Subsidiaries have good and marketable title in fee
simple to all real property owned by them and good and marketable title in all personal property owned by them that is material
to the business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects (“Liens”)
and, except for Liens as do not materially affect the value of such property and do not materially interfere with the use made
and proposed to be made of such property by the Company and its Subsidiaries and Liens for the payment of federal, state or other
taxes, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease
by the Company and its Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and
its Subsidiaries are in compliance with such exceptions as are not material and do not interfere with the use made and proposed
to be made of such property and buildings by the Company and its Subsidiaries.

 

(n)
Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance
coverage sought or applied for and neither the Company nor any such Subsidiary has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not materially and adversely affect the condition, financial
or otherwise, or the earnings, business or operations of the Company and its Subsidiaries, taken as a whole.

 

(o)
Regulatory Permits. The Company and its Subsidiaries possess all material certificates, authorizations and permits issued
by the appropriate federal, state or foreign regulatory authorities necessary to conduct their respective businesses, and neither
the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such
certificate, authorization or permit.

 

(p)
Tax Status. The Company and each of its Subsidiaries has made or filed all federal and state income and all other material
tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that
the Company and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid
and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside
on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns,
reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company know of no basis for any such claim.

 

    	 	-9-	 

     

    

 

(q)
Transactions With Affiliates. Except as set forth in the SEC Documents, none of the officers or directors of the Company
and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company
or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which
any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner, in each
case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for
expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock
option plan of the Company.

 

(r)
Application of Takeover Protections. The Company and its board of directors have taken or will take prior to the Commencement
Date all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Articles of Incorporation
or the laws of the state of its incorporation which is or could become applicable to the Investor as a result of the transactions
contemplated by this Agreement, including, without limitation, the Company’s issuance of the Purchase Shares and the Investor’s
ownership of the Purchase Shares.

 

(s)
Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents that will be timely publicly disclosed by the Company, the Company confirms that neither it nor any other Person acting
on its behalf has provided the Investor or its agents or counsel with any information that it believes constitutes or might constitute
material, non-public information which is not otherwise disclosed in the Registration Statement or the SEC Documents. The Company
understands and confirms that the Investor will rely on the foregoing representation in effecting purchases and sales of securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Investor regarding the Company, its business
and the transactions contemplated hereby, including the disclosure schedules to this Agreement, is true and correct and does not
contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company
during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that the Investor
neither makes nor has made any representations or warranties with respect to the transactions contemplated hereby other than those
specifically set forth in Section 3 hereof.

 

(t)
Foreign Corrupt Practices. Neither the Company, nor to the knowledge of the Company, any agent or other Person acting on
behalf of the Company, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose
fully any contribution made by the Company (or made by any Person acting on its behalf of which the Company is aware) which is
in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

 

    	 	-10-	 

     

    

 

(u)
Registration Statement. The Company has prepared and filed with the SEC in accordance with the provisions of the Securities
Act the Registration Statement. The Registration Statement was declared effective by order of the SEC on August 10, 2018. The
Registration Statement is effective pursuant to the Securities Act and available for the issuance of the Purchase Shares thereunder,
and the Company has not received any written notice that the SEC has issued or intends to issue a stop order or other similar
order with respect to the Registration Statement or the Prospectus or that the SEC otherwise has (i) suspended or withdrawn the
effectiveness of the Registration Statement or (ii) issued any order preventing or suspending the use of the Prospectus or any
Prospectus Supplement, in either case, either temporarily or permanently or intends or has threatened in writing to do so. The
“Plan of Distribution” section of the Prospectus permits the issuance of the Purchase Shares under the terms of this
Agreement. At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and
at each deemed effective date thereof pursuant to Rule 430B(f)(2) of the Securities Act, the Registration Statement and any amendments
thereto complied and will comply in all material respects with the requirements of the Securities Act and did not and will not
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein not misleading; and the Base Prospectus and any Prospectus Supplement thereto, at the time such
Base Prospectus or such Prospectus Supplement thereto was issued and on the Closing Date, complied and will comply in all material
respects with the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading; provided that this representation and warranty does not apply to statements in or omissions from any
Prospectus Supplement made in reliance upon and in conformity with information relating to the Investor furnished to the Company
in writing by or on behalf of the Investor expressly for use therein. The SEC has not notified the Company of any objection to
the use of the form of the Registration Statement pursuant to Rule 401(g)(1) of the Securities Act. The Company hereby confirms
that the issuance of the Purchase Shares to the Investor pursuant to this Agreement would not result in non-compliance with the
Securities Act or any of the General Instructions to Form S-3. The Registration Statement, as of its effective date, meets the
requirements set forth in Rule 415(a)(1)(x) pursuant to the Securities Act. The Company has not distributed any offering material
in connection with the offering and sale of any of the Purchase Shares, and, until the Investor does not hold any of the Purchase
Shares, shall not distribute any offering material in connection with the offering and sale of any of the Purchase Shares, to
or by the Investor, in each case, other than the Registration Statement or any amendment thereto, the Prospectus or any Prospectus
Supplement required pursuant to applicable law or the Transaction Documents. The Company has not made, and agrees that unless
it obtains the prior written consent of the Investor it will not make, an offer relating to the Purchase Shares that would constitute
a “free writing prospectus” as defined in Rule 405 under the Securities Act. The Company shall comply with the requirements
of Rules 164 and 433 under the Securities Act applicable to any such free writing prospectus consented to by the Investor, including
in respect of timely filing with the SEC, legending and record keeping.

 

(v)
DTC Eligibility. The Company, through the Transfer Agent, participates in the DTC Fast Automated Securities Transfer (FAST)
Program to enable the Common Stock can be transferred electronically to third parties via the DTC Fast Automated Securities Transfer
(FAST) Program.

 

    	 	-11-	 

     

    

 

(w)
Sarbanes-Oxley. The Company is in compliance in all material respects with all provisions of the Sarbanes-Oxley Act of
2002, as amended, which are applicable to it as of the date hereof.

 

(x)
Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Investor shall not have any obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section 4(x) that may be due in connection with
the transactions contemplated by the Transaction Documents.

 

(y)
Investment Company. The Company is not required to be registered as, and immediately after receipt of payment for the Purchase
Shares will not be required to be registered as, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended.

 

(z)
Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock pursuant to the Exchange Act nor has the Company received any notification that the SEC is currently contemplating
terminating such registration. Except as disclosed in the SEC Documents, the Company has not, in the twelve (12) months preceding
the date hereof, received any notice from any Person to the effect that the Company is not in compliance with the listing or maintenance
requirements of the Principal Market. Except as disclosed in the SEC Documents, the Company is, and has no reason to believe that
it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.

 

(aa)
Accountants. The Company’s accountants are set forth in the SEC Documents and, to the knowledge of the Company, such
accountants are an independent registered public accounting firm as required by the Securities Act.

 

(bb)
No Market Manipulation. The Company has not, and to its knowledge no Person acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of any of the Purchase Shares, (ii) sold, bid for, purchased, or, paid any compensation
for soliciting purchases of, any of the Purchase Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting
another to purchase any other securities of the Company.

 

(cc)
Shell Company Status. The Company is not currently, and for at least the last 12 months has not been, an issuer identified
in Rule 144(i)(1) under the Securities Act.

 

    	 	-12-	 

     

    

 

5.
COVENANTS.

 

(a)
Filing of Current Report and Initial Prospectus Supplement. The Company agrees that it shall, within the time required
under the Exchange Act, file with the SEC a report on Form 8-K relating to the transactions contemplated by, and describing the
material terms and conditions of, the Transaction Documents (the “Current Report”). The Company further agrees
that it shall, within the time required under Rule 424(b) under the Securities Act, file with the SEC the Initial Prospectus Supplement
pursuant to Rule 424(b)(5) under the Securities Act, which Initial Prospectus Supplement shall specifically relate to the Purchase
Shares and shall describe the material terms and conditions of the Transaction Documents, contain information previously omitted
at the time of effectiveness of the Registration Statement in reliance on Rule 430B under the Securities Act, and disclose all
information relating to the Purchase Shares and the transactions contemplated by the Transaction Documents required to be disclosed
in the Registration Statement and the Prospectus as of the date of the Initial Prospectus Supplement, including, without limitation,
information required to be disclosed in the section captioned “Plan of Distribution” in the Prospectus. The Company
shall permit the Investor to review and comment upon the final pre-filing draft versions of the Current Report and the Initial
Prospectus Supplement at least two (2) Business Days prior to their filing with the SEC and the Company shall give reasonable
consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon the final pre-filing draft
versions of the Current Report and the Initial Prospectus Supplement within one (1) Business Day from the date the Investor receives
them from the Company. The Investor shall furnish to the Company such information regarding itself, the Purchase Shares beneficially
owned by it and the intended method of distribution thereof, including any arrangement between the Investor and any other Person
relating to the sale or distribution of the Purchase Shares, as shall be reasonably requested by the Company in connection with
the preparation and filing of the Current Report and the Initial Prospectus Supplement, and shall otherwise cooperate with the
Company as reasonably requested by the Company in connection with the preparation and filing of the Current Report and the Initial
Prospectus Supplement with the SEC.

 

(b)
Blue Sky. The Company shall take all such action, if any, as is reasonably necessary in order to obtain an exemption for
or to register or qualify (i) the issuance of the Purchase Shares to the Investor under this Agreement and (ii) any subsequent
resale of all Purchase Shares by the Investor, in each case, under applicable securities or “Blue Sky” laws of the
states of the United States in such states as is reasonably requested by the Investor from time to time, and shall provide evidence
of any such action so taken to the Investor.

 

(c)
Listing/DTC. The Company shall promptly secure the listing of all of the Purchase Shares to be issued to the Investor hereunder
on the Principal Market (subject to official notice of issuance) and upon each other national securities exchange or automated
quotation system, if any, upon which the Common Stock is then listed, and shall use commercially reasonable efforts to maintain,
so long as any shares of Common Stock shall be so listed, such listing of all such Purchase Shares. The Company shall use commercially
reasonable efforts to maintain the listing of the Common Stock on the Principal Market and shall comply in all respects with the
Company’s reporting, filing and other obligations under the bylaws or rules and regulations of the Principal Market. Neither
the Company nor any of its Subsidiaries shall take any action that would reasonably be expected to result in the delisting or
suspension of the Common Stock on the Principal Market. The Company shall promptly, and in no event later than the following Business
Day, provide to the Investor copies of any notices it receives from any Person regarding the continued eligibility of the Common
Stock for listing on the Principal Market; provided, however, that the Company shall not be required to provide the Investor copies
of any such notice that the Company reasonably believes constitutes material non-public information and the Company would not
be required to publicly disclose such notice in any report or statement filed with the SEC and under the Exchange Act or the Securities
Act. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 5(c). The Company
shall take all action necessary to ensure that its Common Stock can be transferred electronically as DWAC Shares.

 

(d)
Prohibition of Short Sales and Hedging Transactions. During the term of this Agreement, neither the Investor nor any of
its agents, representatives or affiliates shall in any manner whatsoever enter into or effect, directly or indirectly, any (i)
“short sale” (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii)
hedging transaction, which establishes a net short position with respect to the Common Stock.

 

    	 	-13-	 

     

    

 

(e)
Reserved.

 

(f)
Non-Public Information. Each party hereto agrees not to disclose any Confidential Information of the other party to any
third party and shall not use the Confidential Information for any purpose other than in connection with, or in furtherance of,
the transactions contemplated hereby. Each party hereto acknowledges that the Confidential Information shall remain the property
of the disclosing party and agrees that it shall take all reasonable measures to protect the secrecy of any Confidential Information
disclosed by the other party. The Company confirms that neither it nor any other Person acting on its behalf shall provide the
Investor or its agents or counsel with any information that constitutes or might constitute material, non-public information,
unless a simultaneous public announcement thereof is made by the Company in the manner contemplated by Regulation FD. In the event
of a breach of the foregoing covenant by the Company or any Person acting on its behalf (as determined in the reasonable good
faith judgment of the Investor), in addition to any other remedy provided herein or in the other Transaction Documents, if the
Investor is holding any Purchase Shares at the time of the disclosure of material, non-public information, the Investor shall
have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material,
non-public information without the prior approval by the Company; provided the Investor shall have first provided notice to the
Company that it believes it has received information that constitutes material, non-public information, the Company shall have
at least 24 hours to publicly disclose such material, non-public information prior to any such disclosure by the Investor, the
Company shall have failed to demonstrate to the Investor in writing within such time period that such information does not constitute
material, non-public information, and the Company shall have failed to publicly disclose such material, non-public information
within such time period. The Investor shall not have any liability to the Company, any of its Subsidiaries, or any of their respective
directors, officers, employees, stockholders or agents, for any such disclosure. The Company understands and confirms that the
Investor shall be relying on the foregoing covenants in effecting transactions in securities of the Company.

 

(g)
Reserved.

 

(h)
Taxes. The Company shall pay any and all transfer, stamp or similar taxes that may be payable with respect to the issuance
and delivery of any shares of Common Stock to the Investor made under this Agreement.

 

(i)
Reserved.

 

(j)
Stop Orders. The Company shall advise the Investor promptly (but in no event later than 24 hours) and shall confirm such
advice in writing: (i) of the Company’s receipt of notice of any request by the SEC for amendment of or a supplement to
the Registration Statement, the Prospectus, any Prospectus Supplement or for any additional information; (ii) of the Company’s
receipt of notice of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or prohibiting
or suspending the use of the Prospectus or any Prospectus Supplement, or of the Company’s receipt of any notification of
the suspension of qualification of the Purchase Shares for offering or sale in any jurisdiction or the initiation or contemplated
initiation of any proceeding for such purpose; and (iii) of the Company becoming aware of the happening of any event, which makes
any statement of a material fact made in the Registration Statement, the Prospectus or any Prospectus Supplement untrue or which
requires the making of any additions to or changes to the statements then made in the Registration Statement, the Prospectus or
any Prospectus Supplement in order to state a material fact required by the Securities Act to be stated therein or necessary in
order to make the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in light of the circumstances
under which they were made) not misleading, or of the necessity to amend the Registration Statement or supplement the Prospectus
or any Prospectus Supplement to comply with the Securities Act or any other law. The Company shall not be required to disclose
to the Investor the substance or specific reasons of any of the events set forth in clauses (i) through (iii) of the immediately
preceding sentence, but rather, shall only be required to disclose that the event has occurred. If at any time the SEC shall issue
any stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of the Prospectus
or any Prospectus Supplement, the Company shall use its reasonable best efforts to obtain the withdrawal of such order at the
earliest possible time. The Company shall furnish to the Investor, without charge, a copy of any correspondence from the SEC or
the staff of the SEC to the Company or its representatives relating to the Registration Statement or the Prospectus, as the case
may be.

 

    	 	-14-	 

     

    

 

(k)
Amendments to Registration Statement; Prospectus Supplements. Except as provided in this Agreement and other than periodic
and current reports required to be filed pursuant to the Exchange Act, the Company shall not file with the SEC any amendment to
the Registration Statement or any supplement to the Base Prospectus that refers to the Investor, the Purchase Shares, the Transaction
Documents or the transactions contemplated thereby (including, without limitation, any Prospectus Supplement filed in connection
with the transactions contemplated by the Transaction Documents), in each case with respect to which (a) the Investor shall not
previously have been advised and afforded the opportunity to review and comment thereon at least two (2) Business Days prior to
filing with the SEC, as the case may be, (b) the Company shall not have given due consideration to any comments thereon received
from the Investor or its counsel, or (c) the Investor shall reasonably object, unless the Company reasonably has determined that
it is necessary to amend the Registration Statement or make any supplement to the Prospectus to comply with the Securities Act
or any other applicable law or regulation, in which case the Company shall promptly (but in no event later than 24 hours) so inform
the Investor, the Investor shall be provided with a reasonable opportunity to review and comment upon any disclosure referring
to the Investor, the Transaction Documents or the transactions contemplated thereby, as applicable, and the Company shall expeditiously
furnish to the Investor a copy thereof. In addition, for so long as, in the reasonable opinion of counsel for the Investor, a
Prospectus is required to be delivered in connection with any acquisition or sale of Purchase Shares by the Investor, the Company
shall not file any Prospectus Supplement with respect to the Purchase Shares without furnishing to the Investor as many copies
of such Prospectus Supplement, together with the Prospectus, as the Investor may reasonably request.

 

(l)
Prospectus Delivery. The Company consents to the use of the Prospectus (and of each Prospectus Supplement thereto) in accordance
with the provisions of the Securities Act and with the securities or “blue sky” laws of the jurisdictions in which
the Purchase Shares may be sold by the Investor, in connection with the offering and sale of the Purchase Shares and for such
period of time thereafter as a Prospectus is required by the Securities Act to be delivered in connection with sales of the Purchase
Shares. The Company will make available to the Investor upon request, and thereafter from time to time will furnish to the Investor,
as many copies of the Prospectus (and each Prospectus Supplement thereto) as the Investor may reasonably request for the purposes
contemplated by the Securities Act within the time during which the Prospectus is required by the Securities Act to be delivered
in connection with sales of the Purchase Shares. If during such period of time any event shall occur that in the reasonable judgment
of the Company and its counsel, or in the reasonable judgment of the Investor and its counsel, is required to be set forth in
the Registration Statement, the Prospectus or any Prospectus Supplement or should be set forth therein in order to make the statements
made therein (in the case of the Prospectus or any Prospectus Supplement, in light of the circumstances under which they were
made) not misleading, or if in the reasonable judgment of the Company and its counsel, or in the reasonable judgment of the Investor
and its counsel, it is otherwise necessary to amend the Registration Statement or supplement the Prospectus or any Prospectus
Supplement to comply with the Securities Act or any other applicable law or regulation, the Company shall forthwith prepare and,
subject to Section 5(k) above, file with the SEC an appropriate amendment to the Registration Statement or an appropriate Prospectus
Supplement and in each case shall expeditiously furnish to the Investor, at the Company’s expense, such amendment to the
Registration Statement or such Prospectus Supplement, as applicable, as may be necessary to reflect any such change or to effect
such compliance. The Company shall have no obligation to separately advise the Investor of, or deliver copies to the Investor
of, the SEC Documents, all of which the Investor shall be deemed to have notice of.

 

    	 	-15-	 

     

    

 

(m)
Integration. From and after the date of this Agreement, neither the Company, nor any of its affiliates will, and the Company
shall use its reasonable best efforts to ensure that no Person acting on any of their behalf will, directly or indirectly, make
any offers or sales of any security or solicit any offers to buy any security, under circumstances that would cause this offering
of the Purchase Shares to be integrated with other offerings of securities by the Company in a manner that would require stockholder
approval pursuant to the rules and regulations of the Principal Market on which any of the securities of the Company are listed
or designated, unless stockholder approval is obtained before the closing of such subsequent transaction in accordance with the
rules of such Principal Market.

 

(n)
Use of Proceeds. The Company will use the net proceeds from the offering of the Purchase Shares as described in the Prospectus.

 

(o)
Other Transactions. The Company shall not enter into, announce or recommend to its stockholders any agreement, plan, arrangement
or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability or right
of the Company to perform its obligations under any of the Transaction Documents to which it is a party, including, without limitation,
the obligation of the Company to deliver the Purchase Shares to the Investor in accordance with the terms of this Agreement.

 

6.
TRANSFER AGENT INSTRUCTIONS.

 

On
the Closing Date, the Company shall issue to the Transfer Agent (and any subsequent transfer agent) irrevocable instructions,
in the form heretofore furnished to the Company, to issue the Purchase Shares in accordance with the terms of this Agreement (the
“Irrevocable Transfer Agent Instructions”). All Purchase Shares to be issued to or for the benefit of the Investor
pursuant to this Agreement shall be issued as DWAC Shares. The Company represents and warrants to the Investor that no instruction
other than the Irrevocable Transfer Agent Instructions referred to in this Section 6 will be given by the Company to the Transfer
Agent with respect to the Purchase Shares, and the Purchase Shares shall otherwise be freely transferable on the books and records
of the Company. Certificates and any other instruments evidencing the Purchase Shares shall not bear any restrictive or other
legend. If the Investor effects a sale, assignment or transfer of the Purchase Shares, the Company shall permit the transfer and
shall promptly instruct the Transfer Agent (and any subsequent transfer agent) to issue DWAC Shares in such name and in such denominations
as specified by the Investor to effect such sale, transfer or assignment. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to the Investor. Accordingly, the Company acknowledges that the remedy at law
for a breach of its obligations under this Section 6 will be inadequate and agrees, in the event of a breach or threatened breach
by the Company of the provisions of this Section 6, that the Investor shall be entitled, in addition to all other available remedies,
to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing
economic loss and without any bond or other security being required. The Company shall cause its counsel to issue the legal opinion
referred to in the Irrevocable Transfer Agent Instructions to the Transfer Agent (and any subsequent transfer agent) to the extent
required or requested by the Transfer Agent (or any subsequent transfer agent). Any fees (with respect to the Transfer Agent,
counsel to the Company or otherwise) associated with the issuance of such opinion shall be borne by the Company.

 

    	 	-16-	 

     

    

 

7.
CONDITIONS TO THE COMPANY’S OBLIGATION TO ISSUE AND SELL THE PURCHASE SHARES.

 

The
obligation of the Company hereunder to issue and sell the Purchase Shares to the Investor on the Closing Date is subject to the
satisfaction or, where legally permissible, the waiver of each of the following conditions:

 

(a)
The Investor shall have executed this Agreement and delivered the same to the Company;

 

(b)
No stop order with respect to the Registration Statement shall be pending or threatened by the SEC; and

 

(c)
The representations and warranties of the Investor shall be true and correct in all material respects as of the date hereof and
as of the Closing Date as though made at that time.

 

8.
CONDITIONS TO THE INVESTOR’S OBLIGATION TO PURCHASE THE PURCHASE SHARES.

 

The
obligation of the Investor to purchase the Purchase Shares under this Agreement is subject to the satisfaction or, where legally
permissible, the waiver of each of the following conditions:

 

(a)
The Company shall have executed each of the Transaction Documents to which it is a party and delivered the same to the Investor;

 

(b)
The Common Stock shall be listed or quoted on the Principal Market, trading in the Common Stock shall not have been within the
last 365 days suspended by the SEC;

 

(c)
Reserved;

 

(d)
The representations and warranties of the Company shall be true and correct in all material respects (except to the extent that
any of such representations and warranties is already qualified as to materiality in Section 4 above, in which case, the portion
of such representations and warranties so qualified shall be true and correct without further qualification) as of the date hereof
and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific
date, which shall be true and correct as of such date) and the Company shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied
with by the Company at or prior to the Closing Date. The Investor shall have received a certificate, executed by the CEO, President
or CFO of the Company, dated as of the Closing Date, to the foregoing effect in the form attached hereto as Exhibit A;

 

    	 	-17-	 

     

    

 

(e)
The Board of Directors of the Company shall have adopted resolutions in substantially the form previously provided to the Investor,
which shall be in full force and effect without any amendment or supplement thereto as of the Closing Date;

 

(f)
The Irrevocable Transfer Agent Instructions shall have been delivered to and acknowledged in writing by the Company and the Company’s
Transfer Agent;

 

(g)
The Company shall have delivered to the Investor a certificate evidencing the incorporation and good standing of the Company in
the State of Delaware issued by the Secretary of State of the State of Delaware as of a date within ten (10) Business Days of
the Closing Date.

 

(h)
RESERVED.

 

(i)
RESERVED.

 

(j)
The Registration Statement shall be effective and no stop order with respect to the Registration Statement shall be pending or
threatened by the SEC. The Company shall have a maximum dollar amount certain of securities, including the Purchase Shares, registered
under the Registration Statement which is sufficient to issue to the Investor not less than all of the Purchase Shares to be purchased
under the Purchase Agreement All reports, schedules, registrations, forms, statements, information and other documents required
to have been filed by the Company with the SEC at or during the 12-month period immediately preceding the Closing Date pursuant
to the reporting requirements of the Exchange Act shall have been filed with the SEC within the applicable time periods prescribed
for such filings under the Exchange Act, including any applicable extension periods contemplated by the Exchange Act;

 

(k)
The Company shall be eligible to transfer its Common Stock, including all of the Purchase Shares, electronically as DWAC Shares;

 

(l)
All federal, state and local governmental laws, rules and regulations applicable to the transactions contemplated by the Transaction
Documents and necessary for the execution, delivery and performance of the Transaction Documents and the consummation of the transactions
contemplated thereby in accordance with the terms thereof shall have been complied with, and all consents, authorizations and
orders of, and all filings and registrations with, all federal, state and local courts or governmental agencies and all federal,
state and local regulatory or self-regulatory agencies necessary for the execution, delivery and performance of the Transaction
Documents and the consummation of the transactions contemplated thereby in accordance with the terms thereof shall have been obtained
or made, including, without limitation, in each case those required under the Securities Act, the Exchange Act, applicable state
securities or “Blue Sky” laws or applicable rules and regulations of the Principal Market, or otherwise required by
the SEC, the Principal Market or any state securities regulators;

 

(m)
No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or
endorsed by any federal, state, local or foreign court or governmental authority of competent jurisdiction which prohibits the
consummation of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents;

 

(n)
No action, suit or proceeding before any federal, state, local or foreign arbitrator or any court or governmental authority of
competent jurisdiction shall have been commenced or threatened, and no inquiry or investigation by any federal, state, local or
foreign governmental authority of competent jurisdiction shall have been commenced or threatened, against the Company, or any
of the officers, directors or affiliates of the Company, seeking to restrain, prevent or change the transactions contemplated
by the Transaction Documents, or seeking material damages in connection with such transactions;

 

(o)
No Person shall have commenced a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law;

 

(p)
The Company, pursuant to or within the meaning of any Bankruptcy Law, shall not have (i) commenced a voluntary case, (ii) consented
to the entry of an order for relief against it in an involuntary case, (iii) consented to the appointment of a Custodian of it
or for all or substantially all of its property, or (iv) made a general assignment for the benefit of its creditors or is generally
unable to pay its debts as the same become due; and

 

(q)
A court of competent jurisdiction shall not have entered an order or decree under any Bankruptcy Law that (i) is for relief against
the Company in an involuntary case, (ii) appoints a Custodian of the Company or for all or substantially all of its property,
or (iii) orders the liquidation of the Company or any Subsidiary.

 

    	 	-18-	 

     

    

 

9.
INDEMNIFICATION.

 

In
consideration of the Investor’s execution and delivery of this Agreement and acquiring the Purchase Shares, and in addition
to all of the Company’s other obligations under the Transaction Documents to which it is a party, the Company shall defend,
protect, indemnify and hold harmless the Investor and all of its affiliates, stockholders, officers, directors and employees and
any of the foregoing Person’s agents or other representatives (including, without limitation, those retained in connection
with the transactions contemplated by the Transaction Documents) (collectively, the “Indemnitees”) from and
against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder
is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”),
incurred by any Indemnitee as a result of, or arising out of, or relating to: (a) any misrepresentation or breach of any representation
or warranty made by the Company in any of the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby, (b) any breach of any covenant, agreement or obligation of the Company contained in any of the Transaction
Documents or any other certificate, instrument or document contemplated hereby or thereby, (c) any cause of action, suit or claim
brought or made against such Indemnitee and arising out of or resulting from the execution, delivery, performance or enforcement
of any of the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (d) any violation
of the Securities Act, the Exchange Act, state securities or “Blue Sky” laws, or the rules and regulations of the
Principal Market in connection with the transactions contemplated by the Transaction Documents by the Company or any of its affiliates,
officers, directors or employees, (e) any untrue statement or alleged untrue statement of a material fact contained, or incorporated
by reference, in the Registration Statement or any amendment thereto or any omission or alleged omission to state therein, or
in any document incorporated by reference therein, a material fact required to be stated therein or necessary to make the statements
therein not misleading, or (f) any untrue statement or alleged untrue statement of a material fact contained, or incorporated
by reference, in the Prospectus, or any omission or alleged omission to state therein, or in any document incorporated by reference
therein, a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading; provided, however, that (I) the indemnity contained in clause (c) of this Section
9 shall not apply to any Indemnified Liabilities which directly and primarily result from the fraud, gross negligence or willful
misconduct of an Indemnitee, (II) the indemnity contained in clauses (d), (e) and (f) of this Section 9 shall not apply to any
Indemnified Liabilities to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue
statement or omission or alleged omission made in reliance upon and in conformity with written information furnished to the Company
by or on behalf of the Investor expressly for use in any Prospectus Supplement (it being hereby acknowledged and agreed that the
written information set forth on Exhibit C attached hereto is the only written information furnished to the Company
by or on behalf of the Investor expressly for use in the Initial Prospectus Supplement), if the Prospectus was timely made available
by the Company to the Investor pursuant to Section 5(l), (III) the indemnity contained in clauses (d), (e) and (f) of this Section
9 shall not inure to the benefit of the Investor to the extent such Indemnified Liabilities are based on a failure of the Investor
to deliver or to cause to be delivered the Prospectus made available by the Company, if such Prospectus was timely made available
by the Company pursuant to Section 5(l), and if delivery of the Prospectus by the Investor was required under the Securities Act
with respect to the Purchase Shares and such delivery by the Investor would have cured the defect giving rise to such Indemnified
Liabilities, and (IV) the indemnity in this Section 9 shall not apply to amounts paid in settlement of any claim if such settlement
is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or
delayed. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make
the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable
law. Any required indemnification payment for any particular claim shall be made within thirty (30) days from the date the Investor
makes a written request for it. A certificate containing reasonable detail as to the amount of such indemnification submitted
to the Company by the Investor shall be conclusive evidence, absent manifest error, of the amount due from the Company to the
Investor. If any action shall be brought against any Indemnitee in respect of which indemnity may be sought pursuant to this Agreement,
such Indemnitee shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof
with counsel of its own choosing reasonably acceptable to the Indemnitee. Any Indemnitee shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Indemnitee, except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between the position of
the Company and the position of such Indemnitee, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel.

 

10.
RESERVED.

 

11.
TERMINATION

 

This
Agreement may be terminated only as follows:

 

(a)
If pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding
against the Company, a Custodian is appointed for the Company or for all or substantially all of its property, or the Company
makes a general assignment for the benefit of its creditors, this Agreement shall automatically terminate without any liability
or payment to the Company (except as set forth below) without further action or notice by any Person.

 

    	 	-19-	 

     

    

 

(b)
In the event that the Closing shall not have occurred on or before April 15, 2019,due to the failure to satisfy the conditions
set forth in Sections 7 and 8 above with respect to the Closing, either the Company, on the one hand, or the Investor, on the
other hand, shall have the option to terminate this Agreement at the close of business on such date or thereafter without liability
of any party to any other party (except as set forth below); provided, however, that the right to terminate this Agreement under
this Section 11(b) shall not be available to any party if such party is then in breach of any covenant or agreement contained
in this Agreement or any representation or warranty of such party contained in this Agreement fails to be true and correct such
that the conditions set forth in Section 7(c) or Section 8(d), as applicable, could not then be satisfied. Any termination of
this Agreement pursuant to this Section 11(b) shall be effected by written notice from the Company to the Investor, or the Investor
to the Company, as the case may be, setting forth the basis for the termination hereof.

 

The
representations and warranties and covenants of the Company and the Investor contained in Sections 3, 4, 5, and 6 hereof, the
indemnification provisions set forth in Section 9 hereof and the agreements and covenants set forth in Sections 10, 11 and 12,
shall survive the Closing. Notwithstanding the foregoing, no termination of this Agreement shall be deemed to release the Company
or the Investor from any liability for intentional misrepresentation or willful breach of any of the Transaction Documents to
which it is a party.

 

12.
MISCELLANEOUS.

 

(a)
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State
of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents
(whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees
or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the State of New York, City of New York, Borough
of Manhattan , for the adjudication of any dispute hereunder or under this Agreement and any other Transaction Documents or in
connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action
or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and the other Transaction Documents and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY OF THE OTHER TRANSACTION DOCUMENTS
OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.

 

(b)
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party; provided that a facsimile signature or signature delivered by e-mail in a “.pdf” format data file shall be
considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were
an original signature.

 

    	 	-20-	 

     

    

 

(c)
Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.

 

(d)
Severability. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity
or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or
the validity or enforceability of any provision of this Agreement in any other jurisdiction.

 

(e)
Entire Agreement; Amendment. This Agreement and the other Transaction Documents supersede all other prior oral or written
agreements among the Investor, the Company, their respective affiliates and Persons acting on their behalf with respect to the
subject matter hereof, and this Agreement, the other Transaction Documents and the instruments referenced herein contain the entire
understanding of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein
or therein, neither the Company nor the Investor makes any representation, warranty, covenant or undertaking with respect to such
matters. The Company acknowledges and agrees that is has not relied on, in any manner whatsoever, any representations or statements,
written or oral, other than as expressly set forth in the Transaction Documents. No provision of this Agreement or the other Transaction
Documents may be amended other than by a written instrument signed by both parties hereto.

 

(f)
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon
receipt when sent by facsimile or email (provided confirmation of transmission is mechanically or electronically generated and
kept on file by the sending party); or (iii) one Business Day after deposit with a nationally recognized overnight delivery service,
in each case properly addressed to the party to receive the same. The addresses for such communications shall be:

 

If
to the Company:

 

MGT
Capital Investments, Inc.

512
S. Mangum Street, Suite 408

Durham,
NC 27701

Telephone:

Facsimile:

E-mail:

Attention:
Robert Lowrey

 

With
a copy to (which shall not constitute notice or service of process):

 

Sichenzia
Ross Ference LLP

1185
Avenue of the Americas, 37th Floor

New
York, New York 10036

Telephone:
(212) 930-9700

Facsimile:
(212) 930-9725

E-mail:
jkaplowitz@srfkllp.com

Attention:
Jay Kaplowitz, Esq.

 

    	 	-21-	 

     

    

 

If
to the Investor:

 

Iliad
Research and Trading, L.P.

Attn:
John Fife

303
East Wacker Drive, Suite 1040

Chicago,
Illinois 60601

 

With
a copy to (which shall not constitute notice or service of process):

 

Hansen
Black Anderson Ashcraft PLLC

Attn:
Jonathan Hansen

3051
West Maple Loop Drive, Suite 325

Lehi,
Utah 84043

 

If
to the Transfer Agent:

 

VStock
Transfer, LLC

18
Lafayette Place

Woodmere,
New York 11598

Telephone:
(212) 828-8436

Facsimile:
(646) 536-3179

Attention:
Yoel Goldfeder, Esq.

 

or
at such other address and/or facsimile number and/or to the attention of such other Person as the recipient party has specified
by written notice given to each other party three (3) Business Days prior to the effectiveness of such change. Written confirmation
of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender’s facsimile machine or email account containing the time, date, and recipient facsimile number or
email address, as applicable, and an image of the first page of such transmission or (C) provided by a nationally recognized overnight
delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or email or receipt from a nationally
recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

 

(g)
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and any permitted
successors and assigns of the Company. The Company shall not assign this Agreement or any rights or obligations hereunder without
the prior written consent of the Investor, including by merger or consolidation. The Investor may not assign its rights or obligations
under this Agreement.

 

(h)
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and any permitted successors
and assigns of the Company and, except as set forth in Section 9, is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.

 

(i)
Publicity. The Company shall afford the Investor and its counsel with the opportunity to review and comment upon the form
and substance of, and shall give reasonable consideration to all such comments from the Investor or its counsel on, any press
release, SEC filing or any other public disclosure by or on behalf of the Company relating to the Investor, its purchases hereunder
or any aspect of the Purchase Shares, any of the Transaction Documents or the transactions contemplated thereby, not less than
24 hours prior to the issuance, filing or public disclosure thereof. The Investor must be provided with a final version of any
such press release, SEC filing or other public disclosure at least 24 hours prior to any release, filing or use by the Company
thereof. The Company agrees and acknowledges that its failure to fully comply with this provision constitutes a Material Adverse
Effect.

 

    	 	-22-	 

     

    

 

(j)
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

(k)
No Financial Advisor, Placement Agent, Broker or Finder. The Company represents and warrants to the Investor that it has
not engaged any financial advisor, placement agent, broker or finder in connection with the transactions contemplated hereby.
The Investor represents and warrants to the Company that it has not engaged any financial advisor, placement agent, broker or
finder in connection with the transactions contemplated hereby. The Company shall be responsible for the payment of any fees or
commissions, if any, of any financial advisor, placement agent, broker or finder relating to or arising out of the transactions
contemplated hereby. The Company shall pay, and hold the Investor harmless against, any liability, loss or expense (including,
without limitation, reasonable attorneys’ fees and out of pocket expenses) arising in connection with any such claim.

 

(l)
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.

 

(m)
Remedies, Other Obligations, Breaches and Injunctive Relief. The Investor’s remedies provided in this Agreement,
including, without limitation, the Investor’s remedies provided in Section 9, shall be cumulative and in addition to all
other remedies available to the Investor under this Agreement, at law or in equity (including a decree of specific performance
and/or other injunctive relief), no remedy of the Investor contained herein shall be deemed a waiver of compliance with the provisions
giving rise to such remedy and nothing herein shall limit the Investor’s right to pursue actual damages for any failure
by the Company to comply with the terms of this Agreement. The Company acknowledges that a breach by it of its obligations hereunder
will cause irreparable harm to the Investor and that the remedy at law for any such breach may be inadequate. The Company therefore
agrees that, in the event of any such breach or threatened breach, the Investor shall be entitled, in addition to all other available
remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other
security being required.

 

(n)
Enforcement Costs. If: (i) this Agreement is placed by the Investor in the hands of an attorney for enforcement or is enforced
by the Investor through any legal proceeding; (ii) an attorney is retained to represent the Investor in any bankruptcy, reorganization,
receivership or other proceedings affecting creditors’ rights and involving a claim under this Agreement; or (iii) an attorney
is retained to represent the Investor in any other proceedings whatsoever in connection with this Agreement, then the Company
shall pay to the Investor, as incurred by the Investor, all reasonable costs and expenses including reasonable attorneys’
fees incurred in connection therewith, in addition to all other amounts due hereunder. If this Agreement is placed by the Company
in the hands of an attorney for enforcement or is enforced by the Company through any legal proceeding, then the Investor shall
pay to the Company, as incurred by the Company, all reasonable costs and expenses including reasonable attorneys’ fees incurred
in connection therewith, in addition to all other amounts due hereunder.

 

(o)
Waivers. No provision of this Agreement may be waived other than in a written instrument signed by the party against whom
enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate
as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege.

 

*
* * * *

 

    	 	-23-	 

     

    

 

IN
WITNESS WHEREOF, the Investor and the Company have caused this Agreement to be duly executed as of the date first written
above.

 

	 	THE
    COMPANY:
	 	 
	 	MGT
    CAPITAL INVESTMENTS, INC.
	 	 	 
	 	By:	/s/
    Robert Lowrey
	 	Name:	Robert
    Lowrey
	 	Title:	Chief
    Financial Officer

 

	 	INVESTOR:
	 	 
	 	ILIAD
    RESEARCH AND TRADING, L.P.
	 	 
	 	By:
    Iliad Management, LLC, its General Partner
	 	 
	 	By:
    Fife Trading, Inc., its Manager
	 	 	 
	 	By:	/s/
    John M. Fife
	 	 	John
    M. Fife, President

 

    	 	-24-	 

     

    

 

EXHIBITS

 

	Exhibit
A 	Form of Officer’s Certificate
	Exhibit
B	 Form of Secretary’s Certificate
	Exhibit
C	 Information About the Investor Furnished to the Company

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]